India Juris advises on acquisition of Saitech Medicare

31 January 2010

Protech Biosystems “Protech” is India’s highly progressive health management company involved in research, manufacturing and marketing of branded and generic pharmaceutical formulations. Protech Biosystems exports to Russia & CIS countries, South East Asia, African countries, Latin American countries.

India Juris assisted the Protech in acquisition of majority stakes in Chandigarh, India based pharma company Saitech Medicare Pvt Ltd. The complex transaction involved due diligence, corporate law advise, advise on capital gain tax, shareholders agreements and various other side letters, transfer of registrations and approvals etc.

The transaction was successfully completed to the satisfaction of the client.

News & Deals

India Juris once again leads the league.

REC Ltd. empanels India Juris as legal counsel for its domestic borrowing through institutional bonds and retail/54EC bonds.

IJ acts a investor counsel in Fire.Ai’s Investment

Publications

Policies of Funds, FMEs & other entities in GIFT City

Impact of India-UK Trade Agreement on Energy Sector

India – An Emerging Destination for Foreign Drillers

Newsletters

U.S. Government Opens Door for Alternative Assets in 401(k) Plans

USCIS Revises Child Status Protection Act Age Calculation: What It Means for Immigrant Families

India’s Oil & Gas Sector at a Turning Point: Capacity Expansion, OALP Round 10, and Licensing Reform